 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News Merck & Co. Says European Regulators Recommend Approval of HIV Drug IsentressNovember 19, 2007 European regulators have recommended approval of Merck & Co.'s HIV drug Isentress in combination with other antiretroviral (ARV) treatments, the drug maker announced on Thursday. Isentress is designed to treat HIV in adult patient who have already been receiving ARVs. The recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency will be taken into account by the European Commission, which makes the final decision on whether to approve the drug for use in the European Union. Associated Press 11.15.2007  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
